anti-Oxyntomodulin (OXM) Antibodies

The protein encoded by OXM is actually a preproprotein that is cleaved into four distinct mature peptides. Additionally we are shipping Oxyntomodulin Kits (21) and Oxyntomodulin Proteins (3) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
OXM 2641 P01275
OXM    
OXM    
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Oxyntomodulin Antibodies at antibodies-online.com

Showing 10 out of 56 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated ELISA, WB   50 μg Log in to see 11 to 14 Days
$669.17
Details
Human Rabbit Un-conjugated ELISA   200 μg Log in to see 11 to 14 Days
$1,365.83
Details
Pig Rabbit Un-conjugated ELISA   200 μg Log in to see 11 to 14 Days
$1,365.83
Details
Human Rabbit Un-conjugated IHC Human pancreas cancer tissue was stained by Rabbit Anti-Oxyntomodulin (H,M,R) Antibody Human pancreas cancer tissue was stained by Rabbit Anti-Oxyntomodulin (H,M,R) Antibody 100 μL Log in to see 13 to 15 Days
$675.31
Details
Human Rabbit Un-conjugated ELISA   200 μg Log in to see 11 to 16 Days
$991.57
Details
Human Mouse Un-conjugated ELISA   0.1 mL Log in to see 8 to 11 Days
$418.10
Details
Human Rabbit Un-conjugated ELISA, WB   100 μg Log in to see 11 to 16 Days
$818.71
Details
Human Mouse Alexa Fluor 488 ELISA   0.1 mL Log in to see 10 to 13 Days
$516.98
Details
Human Mouse Alexa Fluor 700 ELISA   0.1 mL Log in to see 10 to 13 Days
$516.98
Details
Human Mouse Alexa Fluor 647 ELISA   0.1 mL Log in to see 10 to 13 Days
$516.98
Details

More Antibodies against Oxyntomodulin Interaction Partners

Human Oxyntomodulin (OXM) interaction partners

  1. GPR119 is the oleoyl-lysophosphatidylinositol receptor that is required for GLP-1 secretion in enteroendocrine cells.

  2. RYGB increased circulating bile acids, ileal Takeda G protein-coupled receptor 5 (TGR5) and mTORC1 signaling activity, as well as GLP-1 production in both mice and human subjects. Inhibition of ileal mTORC1 signaling by rapamycin significantly attenuated the stimulation of bile acid secretion, TGR5 expression and GLP-1 synthesis induced by RYGB in lean and diet-induced obese mice.

  3. Glucagon role in the pathophysiology of type 2 diabetes.[review]

  4. This review summarizes the current knowledge regarding the role of GLP-1 in the protection against oxidative damage and the activation of the Nrf2 signaling pathway. [review]

  5. Study concludes that in healthy subjects, glucagon-like peptide-1 (GLP-1) increases cardiac output acutely due to a GLP-1-induced vasodilation in adipose tissue and skeletal muscle together with an increase in cardiac work.

  6. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

  7. The results demonstrate that glucagon-like peptide-1 and insulin synergistically and additively activate vagal afferent neurons.

  8. DPP-4 activity and GLP-1total levels were higher in patients with microvascular complications associated with T2DM. Contrary to expectations, no negative correlation was seen between GLP-1 and DDP-4 levels. This result suggests the possible inefficacy of DDP-4 activity as a marker to predict in vivo degradation of endogenous GLP-1.

  9. Data suggest that cAMP acts as amplifier of insulin secretion triggered by Ca2+ elevation in beta-cells; both messengers are also positive modulators of glucagon release from alpha-cells, but in this case cAMP signaling may be the important regulator and Ca2+ signaling has a more permissive role. [REVIEW]

  10. This study provides evidence that, in HepG2 cells, GLP-1 may affect cholesterol homeostasis by regulating the expression of miR-758 and ABCA1.

  11. This study reports the transition dipole strengths and frequencies of the amyloid beta-sheet amide I mode for the aggregated proteins amyloid-beta1-40, calcitonin, alpha-synuclein, and glucagon.

  12. genetic association studies in population in China: Data confirm that an SNP in an intron of SLC47A1 (rs2289669) is associated with hypoglycemic response to metformin in patients with newly diagnosed type 2 diabetes; differential increases in basal GLP1 plasma levels are also related to this SNP. (SLC47A1 = solute carrier family 47 member 1; GLP1 = glucagon-like peptide-1)

  13. GLP-2 augmented BRIN BD11 beta-cell proliferation, but was less efficacious in 1.1B4 cells. These data highlight the involvement of GLP-2 receptor signalling in the adaptations to pancreatic islet cell stress.

  14. Everolimus down-regulates the systemic levels of gastrin and glucagon in patients with pancreatic neuroendocrine tumors.

  15. Glucagon-like peptide (GLP-2) stimulates cancer myofibroblast proliferation, migration and invasion; GLP-2 acts indirectly on epithelial cells partly via increased Insulin-like growth factor (IGF) expression in myofibroblasts.

  16. Describe model, in which the release of GIP/GLP-1 is stimulated by glucose in the proximal small intestine, and no differences in the secretion dynamics between healthy individuals and patients with T2D are identified after taking differences in glucose profiles into account.

  17. the solvent exposure of the two Phe sites along the glucagon sequence was determined, showing that 4F-Phe6 was fully solvent exposed and 4F-Phe22 was only partially exposed

  18. Data suggest that dose/intensity-response relationships exist between exercise intensity and total plasma PYY levels, though the effects on total plasma GLP1 levels and hunger perceptions seem unclear. (PYY = peptide YY ; GLP1 = glucagon-like peptide 1)

  19. GLP-2 could be considered an hormone causing positive energy balance, which, however has the role to mitigate the metabolic dysfunctions associated with hyper-adiposity. [review]

  20. Studies indicate that nutrient-induced glucagonlike peptide-1 (GLP-1) response was one of the best predictors of type 2 diabetes mellitus (T2DM) remission after Roux-en-Y-gastric-bypass (RYGB).

Oxyntomodulin (OXM) Antigen Profile

Protein Summary

The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon.

Gene names and symbols associated with anti-Oxyntomodulin (OXM) Antibodies

  • glucagon (GCG) antibody
  • GLP1 antibody
  • GLP2 antibody
  • GRPP antibody

Protein level used designations for anti-Oxyntomodulin (OXM) Antibodies

glicentin-related polypeptide , glucagon-like peptide 1 , glucagon-like peptide 2 , preproglucagon

GENE ID SPECIES
2641 Homo sapiens
Selected quality suppliers for anti-Oxyntomodulin (OXM) Antibodies
Did you look for something else?